Earnings Call · Q2 FY2025·2025-08-13

Q2 25EPS +1.61%·Rev n/aQ1 25EPS +31.08%·Rev n/aQ4 24EPS +27.88%·Rev n/aQ3 24EPS +21.24%·Rev n/a⚠ consensus missing

INOVIO PHARMACEUTICALS, INC. INO

Jennie Willson

Jacqueline E. Shea — President and Chief Executive Officer

Michael Sumner — Chief Medical Officer

Steven Egge — Chief Commercial Officer

Peter D. Kies — Chief Financial Officer

+3.5%1d on move date+2.4% vs SPY3d+12.5%5d+31.9%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more INO calls or request research access.

More INO calls Browse calls Request research access